Home / Medical Devices / Digital Therapeutics Market By Product Type (Software, Devices), By Application (Diabetes, Obesity, Cardiovascular Diseases, CNS Diseases, Respiratory Diseases, Smoking Cessation) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Digital Therapeutics Market By Product Type (Software, Devices), By Application (Diabetes, Obesity, Cardiovascular Diseases, CNS Diseases, Respiratory Diseases, Smoking Cessation) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Published: Nov 2017 | Report Code: 58814-11-17

Digital therapeutics is a platform that utilizes digital tools such as software’s or devices to monitor treatment regimens and also treat medical conditions. This platform builds a bridge between patients, payers and physicians thus helping in monitoring of treatment, ensuring adherence to medications and also curbing the healthcare costs. Owing to an increase in adoption and utilization of the internet, smart phones and tablets, increase in demand for reduced healthcare cost and rising focus on preventive healthcare, the digital therapeutics market is projected to expand during the forecast period, 2017-2025.

The current report compilation on digital therapeutics market comprehends an elaborative market outlook and dynamics along with thorough analysis of the current and upcoming future market scenarios. In depth market evaluation in terms of US$ Mn, forecast analysis with annual growth rates and market evolution along the period, 2017-2025 are some of the key inclusions of this report.

The digital therapeutics market is segmented based on the availability of the various kinds of products in the market, the vivid applications of digital therapeutics and by the outreach of digital therapeutics amongst geographies. Hence, the various market segments incorporated in this report includes product type, application and geographies. The product type is segmented as software’s and devices. Devices are sub-segmented as pain management devices, rehabilitation devices, respiratory therapy devices and glucose monitoring devices. The application segment comprises diabetes, obesity, cardiovascular diseases, CNS diseases, respiratory diseases, smoking cessation and other chronic conditions.

The various geographies studied under this report comprises of North America (Canada & U.S.A), Europe (Germany, United Kingdom & Rest of Europe), Asia Pacific (India, Japan & Rest of Asia Pacific), Latin America (Mexico, Brazil & Rest of Latin America) and Middle East and Africa (GCC & Rest of Middle East and Africa). The aforementioned segments are studied in depth and market estimations and forecast analysis for each of the segments are performed. Market share in terms of US$ Mn for each of the segments has been incorporated along with their respective growth rates.

The report also encompasses qualitative factors such as market drivers, restraints and market opportunities that would help gauge a better understanding of the market dynamics and market trends of digital therapeutics. Digital therapeutics market is comprised of a large competitive pool. Constant partnerships, device withdrawals, advanced device additions in the market are few market trends that change the market outlooks. A comprehensive explanation of market attractiveness analysis, competitive landscape, partnership and collaborations, and upcoming advancements in the forecast period are included in this report. Additionally the report also comprises of profiles of dominant players holding strong positions in the digital therapeutics market. The dominant players profiled in the current report are Omada Health, Inc., Evolent Health, Inc., Perfint Healthcare Pvt. Ltd., Nanobiosym, Inc., Zest Health, Doximity, Inc., Pear Therapeutics, Inc., Evolent Health, Inc., WellDoc Inc., 2Morrow, Inc., Proteus Digital Health, Livongo Health, Twinehealth, Inc., Propeller Health, Mango Health, Inc., Canary Health, Inc., Noom Health, Inc. & Others.

Digital Therapeutics Market

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Digital Therapeutics Market Portraiture
2.1.1. Global Digital Therapeutics Market, by Product Type, 2016 (US$ Mn)
2.1.2. Global Digital Therapeutics Market, by Application, 2016 (US$ Mn)
2.1.3. Global Digital Therapeutics Market, by Geography, 2016 vs. 2025 (US$ Mn)

Chapter 3. Global Digital Therapeutics Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Digital Therapeutics: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Digital Therapeutics Market, by Product Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Digital Therapeutics Market, by Product Type , 2016
4.2. Software
4.3. Devices
4.3.1. Pain management Devices
4.3.2. Rehabilitation Devices
4.3.3. Respiratory Therapy Devices
4.3.4. Glucose Monitoring Devices

Chapter 5. Global Digital Therapeutics Market, by Application , 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Digital Therapeutics Market, byApplication Type, 2016
5.2. Diabetes
5.3. Obesity
5.4. Cardiovascular Diseases
5.5. CNS Diseases
5.6. Respiratory Diseases
5.7. Smoking Cessation
5.8. Others

Chapter 6. Global Digital Therapeutics Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Digital Therapeutics Market Analysis, 2015 – 2025
6.2.1. North America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.2.2. North America Digital Therapeutics Market, by Application , 2015 – 2025(US$ Mn)
6.2.3. North America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Digital Therapeutics Market Analysis, 2015 – 2025
6.3.1. Europe Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.3.2. Europe Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.3.3. Europe Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Digital Therapeutics Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.4.2. Asia Pacific Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.4.3. Asia Pacific Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Digital Therapeutics Market Analysis, 2015 – 2025
6.5.1. Latin America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.5.2. Latin America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.5.3. Latin America Digital Therapeutics Market, by Country, 2015 – 2025(US$ Mn)
6.5.3.1. Mexico
6.5.3.2. Brazil
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Digital Therapeutics Market Analysis, 2015 – 2025
6.6.1. MEA Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.6.2. MEA Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.6.3. MEA Digital Therapeutics Market, by Country, 2015 – 2025(US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. 2Morrow, Inc.
7.1.1. Business Description
7.1.2. Financial Information(Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Canary Health, Inc.
7.3. Doximity, Inc.
7.4. Evolent Health, Inc.
7.5. Livongo Health
7.6. Mango Health, Inc.
7.7. Nanobiosym, Inc.
7.8. Noom Health, Inc.
7.9. Omada Health, Inc.
7.10. Pear Therapeutics, Inc.
7.11. Perfint Healthcare Pvt. Ltd.
7.12. Propeller Health
7.13. Proteus Digital Health
7.14. Twinehealth, Inc.
7.15. WellDoc Inc.
7.16. Zest Health

List of Tables :

TABLE 1 Global Digital Therapeutics Market Share, by Product Type, 2016 (US$ Mn)
TABLE 2 Global Digital Therapeutics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 3 Global Digital Therapeutics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Digital Therapeutics Market, by Product Type , 2015 – 2025(US$ Mn)
TABLE 5 North America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 6 North America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 8 Europe Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 9 Europe Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 11 Asia Pacific Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 12 Asia Pacific Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 14 Mn)
TABLE 15 Latin America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 16 Latin America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East And Africa Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 18 (US$ Mn)
TABLE 19 Middle East And Africa Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 20 Middle East And Africa Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 2Morrow, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Canary Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Doximity, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Evolent Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Livongo Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Mango Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Nanobiosym, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Noom Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Omada Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Pear Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Perfint Healthcare Pvt. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Propeller Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Proteus Digital Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Twinehealth, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 WellDoc Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Zest Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List of Figures :

FIG. 1 Digital Therapeutics: Market Segmentation
FIG. 2 Attractive Investment Proposition, by Geography, 2016
FIG. 3 Market Competition Landscape, by Key Players, 2016
FIG. 4 Global Software Market In Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 5 Global Pain Management Devices Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 6 Global Rehabilitation Devices Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 7 Global Respiratory Therapy Devices Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 8 Global Glucose Monitoring Devices Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 9 Global Diabetes Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 10 Global Obesity Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 11 Global Cardiovascular Diseases Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 12 Global CNS Diseases Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 13 Global Respiratory Diseases Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 14 Global Smoking Cessation Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 15 Global Other Application Market in Digital Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 16 U.S. Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 17 Canada Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 18 U.K. Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 19 Germany Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 20 Rest Of Europe Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 21 Japan Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 22 China Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 23 Rest Of Asia Pacific Digital Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Digital Therapeutic Market 2015-2025 (US$ Mn)
FIG. 25 Brazil Digital Therapeutics Market 2015-2025 (US$ Mn)
FIG. 26 Rest of Latin America Digital Therapeutics Market 2015-2025 (US$ Mn)
FIG. 27 GCC Digital Therapeutics Market 2015-2025 (US$ Mn)
FIG. 28 Rest of MEA Digital Therapeutics Market 2015-2025 (US$ Mn)

Based on the product types, the global digital therapeutics market is segmented as follows:

  • Software
  • Devices
    • Pain management devices
    • Rehabilitation devices
    • Respiratory therapy devices
    • Glucose monitoring devices

Digital therapeutic products are either in the form of a software or a device. Software and devices provide the required lifestyle modification guidance and treatment monitoring features. The software segment dominates the digital therapeutics market owing to ease of availability, reduced cost in comparison to devices, accessibility on smart phones and patient friendly interface. Software’s store the daily monitored data into a cloud based system, which could be retrieved as and when required. This integrated system creates a bridge between the caregivers and patients, thus attaining timely patient care. Software’s or devices help implement treatment programs specific to major chronic diseases like diabetes, heart disease, high blood pressure, and pulmonary diseases like COPD. These solutions helps to limit and prevent the severity of life-threatening conditions with lifestyle behavioral changes. The devices segment is expected to show a moderate growth during the forecast period owing to the lack of awareness and availability of such digital therapeutic devices in the developing economies. However, rising prescriptions from physicians would display a substantial growth of digital therapeutics market.

 Digital Therapeutics Market

Based on applications, the global digital therapeutics market is segmented as follows:

  • Diabetes
  • Obesity
  • Cardiovascular Diseases
  • CNS Diseases
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital therapeutics is predominantly accepted and utilized for chronic disease management. The most common type of chronic diseases mentioned in the study include diabetes, obesity, cardiovascular diseases, CNS diseases, respiratory diseases and others. Diabetes held the largest market share when compared to other areas in the digital therapeutics market. Diabetes segment holds the highest potential in the digital therapeutics market as it is a lifestyle related disorder and the prevalence of diabetes is on the rise globally. According to the International Diabetes Federation (IDF), 415 million individuals had diabetes in 2015, which is projected to reach 642 million by 2040. Digital therapeutic techniques help in monitoring insulin/oral anti-hyperglycemic treatment on a regular basis resulting in patient adherence. Obesity held the second largest market by application for digital therapeutics owing to the growing obesity cases and rising awareness regarding fitness among the masses. As per the World Health Organization (WHO) obesity accounted for 13% of the world’s population in the year 2016. Digital therapeutic techniques helps in fitness management and weight reduction by monitoring daily lifestyle patterns, periodic reminders for exercise and calorie monitoring.

Digital Therapeutics Market  

For the purpose of this study, the digital therapeutics market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Digital Therapeutics Market

Among the aforementioned regions, North America accounts for major share in the digital therapeutic market. The factors that propel this market are developed healthcare infrastructure with improving reimbursement policies, drive towards attaining a patient-centric healthcare approach and technological advancements in healthcare monitoring are the major factors that drive this market. Increasing number of digital therapy providers in North America also accounts to the growth in this market region. The market for Asia Pacific is anticipated to rise at an increased rate during the forecast duration 2017-2025. The rise in growth of Asia Pacific market can be attributed to market drivers such as rising chronic disease population, increasing availability and acceptance of latest healthcare technologies. Additionally, constant development of healthcare infrastructure and efforts to maintain sustainable healthcare growth by financial inclusions drives this market.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients